277 related articles for article (PubMed ID: 33475252)
21. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
Landau D; London L; Bandach I; Segev Y
PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin (EPO) as a Key Regulator of Erythropoiesis, Bone Remodeling and Endothelial Transdifferentiation of Multipotent Mesenchymal Stem Cells (MSCs): Implications in Regenerative Medicine.
Tsiftsoglou AS
Cells; 2021 Aug; 10(8):. PubMed ID: 34440909
[TBL] [Abstract][Full Text] [Related]
24. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
25. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
Han Y; Gao C; Liu Y; Zhang H; Wang S; Zhao H; Bao W; Guo X; Vinchi F; Lobo C; Shi P; Mendelson A; Luchsinger L; Zhong H; Yazdanbakhsh K; An X
Blood; 2024 Mar; 143(11):1018-1031. PubMed ID: 38127913
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin mediated bone formation is regulated by mTOR signaling.
Kim J; Jung Y; Sun H; Joseph J; Mishra A; Shiozawa Y; Wang J; Krebsbach PH; Taichman RS
J Cell Biochem; 2012 Jan; 113(1):220-8. PubMed ID: 21898543
[TBL] [Abstract][Full Text] [Related]
27. Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome.
Shimizu R; Komatsu N; Miura Y
Exp Hematol; 1999 Feb; 27(2):229-33. PubMed ID: 10029161
[TBL] [Abstract][Full Text] [Related]
28. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
Menon MP; Karur V; Bogacheva O; Bogachev O; Cuetara B; Wojchowski DM
J Clin Invest; 2006 Mar; 116(3):683-94. PubMed ID: 16511603
[TBL] [Abstract][Full Text] [Related]
29. Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation.
Chen ZY; Asavaritikrai P; Prchal JT; Noguchi CT
J Biol Chem; 2007 Aug; 282(35):25875-83. PubMed ID: 17604282
[TBL] [Abstract][Full Text] [Related]
30. Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia.
Alamo IG; Kannan KB; Smith MA; Efron PA; Mohr AM
J Trauma Acute Care Surg; 2016 Oct; 81(4):705-12. PubMed ID: 27398985
[TBL] [Abstract][Full Text] [Related]
31. Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia.
Nalbant D; Saleh M; Goldman FD; Widness JA; Veng-Pedersen P
J Pharmacol Exp Ther; 2010 May; 333(2):528-32. PubMed ID: 20103588
[TBL] [Abstract][Full Text] [Related]
32. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) stimulates primitive and definitive erythropoiesis in mouse embryos expressing hGM-CSF receptors but not erythropoietin receptors.
Hisakawa H; Sugiyama D; Nishijima I; Xu MJ; Wu H; Nakao K; Watanabe S; Katsuki M; Asano S; Arai K; Nakahata T; Tsuji K
Blood; 2001 Dec; 98(13):3618-25. PubMed ID: 11739165
[TBL] [Abstract][Full Text] [Related]
33. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
[TBL] [Abstract][Full Text] [Related]
34. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
35. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
36. A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.
Brigandi RA; Johnson B; Oei C; Westerman M; Olbina G; de Zoysa J; Roger SD; Sahay M; Cross N; McMahon L; Guptha V; Smolyarchuk EA; Singh N; Russ SF; Kumar S;
Am J Kidney Dis; 2016 Jun; 67(6):861-71. PubMed ID: 26827289
[TBL] [Abstract][Full Text] [Related]
37. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.
Sathyanarayana P; Dev A; Pradeep A; Ufkin M; Licht JD; Wojchowski DM
Blood; 2012 Jun; 119(23):5522-31. PubMed ID: 22508938
[TBL] [Abstract][Full Text] [Related]
38. The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery.
Caprara C; Britschgi C; Samardzija M; Grimm C
Mol Vis; 2014; 20():307-24. PubMed ID: 24644405
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.
Liu W; Varier KM; Sample KM; Zacksenhaus E; Gajendran B; Ben-David Y
Adv Exp Med Biol; 2020; 1223():17-30. PubMed ID: 32030683
[TBL] [Abstract][Full Text] [Related]
40. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis.
Forejtnikovà H; Vieillevoye M; Zermati Y; Lambert M; Pellegrino RM; Guihard S; Gaudry M; Camaschella C; Lacombe C; Roetto A; Mayeux P; Verdier F
Blood; 2010 Dec; 116(24):5357-67. PubMed ID: 20826723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]